Clinical Trials Logo

Premature Birth clinical trials

View clinical trials related to Premature Birth.

Filter by:

NCT ID: NCT05520359 Recruiting - Stroke Clinical Trials

Spinal Stimulation and Mobility Devices

Start date: August 4, 2022
Phase: N/A
Study type: Interventional

This research study will combine non-invasive spinal stimulation with mobility devices to examine the acute impact of the individual and combined effects of these innovative techniques on mobility in children with cerebral palsy.

NCT ID: NCT05520021 Recruiting - Pregnancy Preterm Clinical Trials

The Treatment of Magnesium Sulfate and Nifedipine in Preterm Labor Threat

MgSO4
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Comparison of the effects of Nifedipine and MgSO4 therapies on maternal and fetal blood flow.

NCT ID: NCT05515614 Recruiting - Premature Birth Clinical Trials

Targeted Nutrition for Moderate to Late Preterm Infants

Start date: August 17, 2022
Phase: N/A
Study type: Interventional

This study will be comparing the postnatal growth of moderate to late preterm infants in the Neonatal Intensive Care Unit (NICU) born between gestational ages of 30 weeks 0 days to 35 weeks and 6 days who are receiving enteral feeds of mother's own breast milk using the NICU's standard nutritional fortification protocol versus a targeted nutritional fortification protocol.

NCT ID: NCT05501938 Recruiting - Preterm Birth Clinical Trials

Physical Exam Indicated Cerclage in Singleton Gestation 24 Weeks to 25 Weeks and 6 Days Gestation

Start date: August 11, 2022
Phase: N/A
Study type: Interventional

RCT assessing preterm delivery rate in singleton pregnancies having a physical-exam indicated cerclage placed between 24 weeks and 25 weeks and 6 days. Patients randomized to either cerclage intervention or routine standard of care (no cerclage).

NCT ID: NCT05496790 Recruiting - Clinical trials for Cardiovascular Diseases

Role of LipoprotEin(a) in CardiovascuLar Diseases and Premature Acute Coronary Syndromes - (RELACS) Study

RELACS
Start date: January 1, 2021
Phase:
Study type: Observational [Patient Registry]

Several clinical and preclinical studies have focused interest on lipoprotein(a) [Lp(a)], showing a direct and independent relationship of its circulating levels with the progression of atherosclerosis and its clinical manifestations. However, to date, Lp(a) represents an underestimated predictor of CV risk, especially in higher-risk populations, such as patients with strong CV familiarity and recurrent and/or early-onset CV events. The key point of the project will be the evaluation of the role of Lp(a) in the development of atherosclerotic disease and, specifically, acute coronary syndrome.

NCT ID: NCT05485610 Recruiting - Clinical trials for Diminished Ovarian Reserve

Effect of NMN (Nicotinamide Mononucleotide) on Diminished Ovarian Reserve (Including Premature Ovarian Insufficiency)

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to understand the effect of nicotinamide mononucleotide (NMN) on patients with diminished ovarian reserve (including premature ovarian insufficiency).

NCT ID: NCT05484726 Recruiting - Preterm Birth Clinical Trials

Maternal Role in Oral Feed Establishment in Preterm Neonates

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

Hypothesis Preterm babies who receive sensory motor stimulation from their mothers as compared to trained nurses will 1. Start taking oral feed at the same time as compared to control group 2. Take the same amount of milk at the commencement of oral feeding 3. Take milk with equal efficiency 4. Not face more adverse effects

NCT ID: NCT05477381 Recruiting - Preterm Birth Clinical Trials

Cervical Softening and the Prediction of Preterm Birth

STIPP
Start date: August 18, 2022
Phase:
Study type: Observational

Currently, transvaginal cervical length measurement is used to screen in asymptomatic pregnant women with a history of PTB. In symptomatic women, presenting with threatened PTB cervical length in combination with the fibronectin test is used to identify women at high risk to deliver preterm. However, the predictive capacity of transvaginal cervical length measurement is limited. In pregnant women with a history of PTB, it only identifies a proportion of women who will have recurrent PTB. For symptomatic women, 30-60% of these women admitted to the hospital, do not deliver within seven days, leading to overtreatment of these women. Cervical softening is precursor of cervical shortening, effacement and dilatation and therefore cervical softening is a promising new marker that is based on tissue elasticity. However, the predictive value of cervical softening and the relation with spontaneous PTB still has to be determined. With the newly developed Pregnolia® System cervical softness could be measured on a standardized and safe manner. This study could help to improve care for women with a history of spontaneous PTB.

NCT ID: NCT05446389 Recruiting - Preterm Birth Clinical Trials

PAL to Improve Oral Feeding for Infants With Chronic Lung Disease

Start date: June 8, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effects of the Pacifier Activated Lullaby (PAL) intervention on the transition to oral feeding for preterm infants with chronic lung disease and respiratory distress syndrome that require non-invasive respiratory support at 34 weeks PMA. This study will utilize a clinical trial design. Participants will be randomized into two groups. One group will receive the PAL intervention, the other group serving as a no contact control. Participants will be matched based on sex, gestational age at birth, and neurologic injury. Infants in the intervention group will receive two PAL sessions a week until successfully transitioned to <2L of respiratory support and then receive one PAL session within 24 hours of their first oral feeding attempt.

NCT ID: NCT05431452 Recruiting - Preterm Birth Clinical Trials

Reducing Pain During Heel Blood Collection in Preterm Newborns

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

Pharmacological and non-pharmacological methods are used to control interventional pain in preterm newborns. Non-pharmacological methods should be preferred in the management of pain, especially during painful minor invasive procedures (blood collection, orogastric tube insertion, aspiration, etc.) applied during the day. Some of these methods are; kangaroo care, breast milk, fetal positioning, breastfeeding, listening to music and massage. Taking heel blood from babies who are being treated in the neonatal intensive care unit is among the duties, authorities and responsibilities of neonatal intensive care nurses. In addition, the effective management of pain by using non-pharmacological methods is among the professional ethical responsibilities of nurses working in neonatal intensive care units. While fulfilling these responsibilities, nurses should conduct researches with high levels of evidence and benefit from the researches effectively. In this context, determining the most effective non-pharmacological method and activating it in a clinical setting form the basis of nursing practices. In this context, the aim of our research is; The aim of this study is to evaluate the effects of fetal position, kangaroo care, combined fetal position with breast milk and breast milk, and kangaroo care in reducing pain during heel blood collection in preterm newborns.